Advertisement
Research Article| Volume 2, ISSUE 3, P247-251, July 2013

Download started.

Ok

To tell or not to tell? Revealing the diagnosis in multiple sclerosis

  • A. Raphael
    Correspondence
    Corresponding author. Tel.: +44 7411990948.
    Affiliations
    Institute for Science, Ethics and Innovation, Centre for Social Ethics and Policy, School of Law, University of Manchester, Oxford Road, Manchester M13 9PL, UK
    Search for articles by this author
  • C.H. Hawkes
    Affiliations
    Neuroscience Centre, Blizard Institute of Cell and Molecular Science, Barts and The London School of Medicine and Dentistry, 4 Newark Street, London E1 2AT, UK
    Search for articles by this author
  • J.L. Bernat
    Affiliations
    Department of Neurology, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire 03756, USA
    Search for articles by this author
Published:February 04, 2013DOI:https://doi.org/10.1016/j.msard.2012.12.007

      Abstract

      We review briefly (1) the history of patient-physician relationship and its evolution from a physician-centered to patient-centered model; (2) the impact of the McDonald Criteria for Multiple Sclerosis (MS); (3) why it is important to tell patients of their diagnosis; (4) how physicians should disclose the diagnosis to patients; (5) dealing with suspected MS; and (6) prognosis and treatment. For the majority of clinically definite MS patients we advocate disclosure, identify steps for physicians to communicate the diagnosis and propose a framework to follow when revealing a diagnosis of MS.

      Highlights

      • We review the evolution of patient-centered medicine and the disclosure of diagnosis in MS.
      • Third revision of McDonald diagnostic criteria accelerates confirmation of diagnosis.
      • Patient's autonomy and availability of disease modifying treatments encourage early diagnosis.
      • Communications techniques were identified to help physicians revealing a diagnosis of MS.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Multiple Sclerosis and Related Disorders
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Baile W.F.
        • Buckman R.
        • Lenzi R.
        • Glober G.
        • Beale E.A.
        • Kudelka A.P.
        SPIKES-A six-step protocol for delivering bad news: application to the patient with cancer.
        The Oncologist. 2000; 5: 302-311
        • Bernat J.L.
        Ethical Issues in Neurology.
        3rd ed. Lippincott Williams & Wilkins, Philadelphia2008
      1. Brazier M. Medicine, Patients and The Law 1st ed. Penguin; 1987

        • Bronnum-Hansen H.
        • Stenager E.
        • Hansen T.
        • Koch-Henriksen N.
        Survival and mortality rates among Danes with MS.
        The International MS Journal. 2006; 13: 66-71
        • Brooks N.A.
        • Matson R.R.
        Social-psychological adjustment to multiple sclerosis: a longitudinal study.
        Social Science & Medicine. 1982; 16: 2129-2135
      2. Buckman R, Kason Y. How to break bad news: a guide for health care professionals: JHU Press; 1992.

        • Buckman R.
        Breaking bad news: why is it still so difficult?.
        British Medical Journal (Clinical research ed). 1984; 288: 1597
        • Comi G.
        • Filippi M.
        • Barkhof F.
        • Durelli L.
        • Edan G.
        • Fernández O.
        • et al.
        Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study.
        The Lancet. 2001; 357: 1576-1582
        • Comi G.
        Shifting the paradigm toward earlier treatment of multiple sclerosis with interferon beta.
        Clinical Therapeutics. 2009; 31: 1142-1157
      3. Compston A, Confavreux Ch, Lassman H, McDonald I, Miller D, Noseworthy J, et al. McAlpine's multiple sclerosis; 2005 4th ed. UK

        • Dias L.
        • Chabner B.A.
        • Lynch Jr, T.J.
        • Penson R.T.
        Breaking bad news: a patient's perspective.
        The Oncologist. 2003; 8: 587-596
        • Elian M.
        • Dean G.
        To tell or not to tell the diagnosis of multiple sclerosis.
        The Lancet. 1985; 326: 27-28
        • Fallowfield L.
        • Jenkins V.
        Communicating sad, bad, and difficult news in medicine.
        The Lancet. 2004; 363: 312-319
        • Fallowfield L.
        Giving sad and bad news.
        The Lancet. 1993; 341: 476-478
        • Ford H.
        • Johnson M.
        Telling your patient he/she has multiple sclerosis.
        Postgraduate Medical Journal. 1995; 71: 449-452
      4. Freedman B. Offering truth: one ethical approach to the uninformed cancer patient. Archives of Internal Medicine. 1993;153(5):572.

        • Granberg T.
        • Martola J.
        • Kristoffersen-Wiberg M.
        • Aspelin P.
        • Fredrikson S.
        Radiologically isolated syndrome – incidental magnetic resonance imaging findings suggestive of multiple sclerosis, a systematic review.
        Multiple Sclerosis. 2012; (Jul 3. [Epub ahead of print])
        • Heesen C.
        • Kolbeck J.
        • Gold S.M.
        • Schulz H.
        • Schulz K.H.
        Delivering the diagnosis of MS - results of a survey among patients and neurologists.
        Acta Neurologica Scandinavica. 2003; 107: 363-368
      5. Higgs R. On telling patients the truth. Moral dilemmas in modern medicine Oxford: OUP. 1985.

        • Kuhse H.
        • Singer P.A.
        Companion to bioethics.
        2nd ed. Blackwell, Oxford2006
        • Levine C.
        Delaying the diagnosis: truth-telling and multiple sclerosis.
        The Hastings Center Report. 1983; 13: 2-3
      6. Lo B. Avoiding deception and nondisclosure. In Lo B. Resolving ethical dilemmas: a guide for clinicians, 4th ed. Baltimore: Lippincott Williams & Wilkinsons, 2009.

      7. Maguire P, Fairbairn S, Fletcher C. Consultation skills of young doctors: II—Most young doctors are bad at giving information. British Medical Journal (Clinical research ed). 1996; 292(6535):1576.

        • Maynard D.W.
        On “realization” in everyday life: the forecasting of bad news as a social relation.
        American Sociological Review. 1996; : 109-131
        • McDonald W.I.
        • Compston A.
        • Edan G.
        • et al.
        Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.
        Annals of Neurology. 2001; 50: 121-127
        • McFarlane J.
        • Riggins J.
        • Smith T.J.
        SPIKE$: a six-step protocol for delivering bad news about the cost of medical care.
        Journal of Clinical Oncology. 2008; 26: 4200-4204
        • Meredith C.
        • Symonds P.
        • Webster L.
        • Lamont D.
        • Pyper E.
        • Gillis C.R.
        • et al.
        Information needs of cancer patients in West Scotland: cross sectional survey of patients' views.
        Bmj. 1996; 313: 724-726
        • Miyaji N.T.
        The power of compassion: truth-telling among American doctors in the care of dying patients.
        Social Science & Medicine. 1993; 36: 249-264
        • Mushlin A.I.
        • Mooney C.
        • Grow V.
        • Phelps C.E.
        The value of diagnostic information to patients with suspected multiple sclerosis.
        Archives of Neurology. 1994; 51: 67
        • Oken D.
        What to tell cancer patients.
        JAMA: The Journal of the American Medical Association. 1961; 175: 1120
        • O'Neill O.
        Autonomy and trust in bioethics.
        Cambridge University Press, 2002
        • Polman C.H.
        • Reingold S.C.
        • Banwell B.
        • Clanet M.
        • Cohen J.A.
        • Filippi M.
        • et al.
        Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria.
        Annals of Neurology. 2011; 69: 292-302
        • Ptacek J.
        • Eberhardt T.L.
        Breaking bad news.
        JAMA: The Journal of the American Medical Association. 1996; 276: 496
        • Rabow M.W.
        • Mcphee S.J.
        Beyond breaking bad news: how to help patients who suffer.
        Western Journal of Medicine. 1999; 171: 260
        • Salander P.
        Bad news from the patient’s perspective: an analysis of the written narratives of newly diagnosed cancer patients.
        Social Science & Medicine. 2002; 55: 721-732
        • Solari A.
        • Acquarone N.
        • Pucci E.
        • Martinelli V.
        • Marrosu M.G.
        • Trojano M.
        • et al.
        communicating the diagnosis of multiple sclerosis – a qualitative study.
        Multiple Sclerosis. 2007; 13: 763-769
        • Storstein A.
        Communication and neurology – bad news and how to break them.
        Acta Neurologica Scandinavica. 2011; 124: 5-11
        • Sullivan R.J.
        • Menapace L.W.
        • White R.M.
        Truth-telling and patient diagnoses.
        Journal of Medical Ethics. 2001; 27: 192
        • Swanton J.K.
        • Fernando K.
        • Dalton C.M.
        Modifi cation of MRI criteria for multiple sclerosis in patients with clinically isolated syndromes.
        Journal of Neurology, Neurosurgery, and Psychiatry. 2006; 77: 43
        • Swanton J.K.
        • Rovira A.
        • Tintore M.
        MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study.
        Lancet Neurology. 2007; 6: 677-686
        • Vandekieft G.K.
        Breaking bad news.
        American Family Physician. 2001; 64: 1975